$STSS
Sharps Technology Inc. Stock $stss

$stss Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223041085 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.096M	$2.130M	$1.339M
YoY Change	1.91%	59.02%	35.93%
% of Gross Profit
Research & Development	$262.2K	$225.2K	$457.6K
YoY Change	-65.5%	-50.79%	28.59%
% of Gross Profit
Depreciation & Amortization	$222.2K	$210.0K	$127.1K
YoY Change	-40.17%	65.24%	4695.85%
% of Gross Profit
Operating Expenses	$2.358M	$2.358M	$1.797M
YoY Change	-16.28%	31.23%	33.98%
Operating Profit		-$2.358M	-$1.797M
YoY Change		31.23%	33.98%
Interest Expense	-$425.0K	$10.00K	$19.34K
YoY Change	-107.87%	-48.29%	64366.67%
% of Operating Profit
Other Income/Expense, Net	$211.5K	$336.0K	-$601.0K
YoY Change	-106.16%	-155.9%	-1821457.58%
Pretax Income	-$3.132M	-$2.020M	-$2.398M
YoY Change	268.61%	-15.77%	78.8%
Income Tax	-$30.00K
% Of Pretax Income
Net Earnings	-$3.102M	-$2.022M	-$2.398M
YoY Change	265.08%	-15.67%	78.8%
Net Earnings / Revenue
Basic Earnings Per Share		-$0.17	-$0.26
Diluted Earnings Per Share	-$0.17	-$0.17	-$260.5K
COMMON SHARES
Basic Shares Outstanding	15.27M shares	11.66M shares	9.207M shares
Diluted Shares Outstanding		11.81M shares	9.207M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.013M	$5.550M	$6.390M
YoY Change	-27.76%	-13.14%	2458.9%
Cash & Equivalents	$3.013M	$5.554M	$6.390M
Short-Term Investments
Other Short-Term Assets	$116.5K	$90.00K	$76.44K
YoY Change	74.55%	17.74%	-35.21%
Inventory	$1.709M	$1.287M	$233.7K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$4.839M	$6.932M	$6.700M
YoY Change	9.38%	3.46%	1722.14%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.822M	$6.913M	$6.644M
YoY Change	-2.61%	4.04%	474.16%
Goodwill
YoY Change
Intangibles	$52.51K	$52.82K	$55.43K
YoY Change	-15.95%	-4.71%
Long-Term Investments
YoY Change
Other Assets	$76.06K	$526.8K	$188.7K
YoY Change	-81.51%	179.15%	-91.35%
Total Long-Term Assets	$6.951M	$7.440M	$6.833M
YoY Change	-6.28%	8.88%	104.65%
TOTAL ASSETS
Total Short-Term Assets	$4.839M	$6.932M	$6.700M
Total Long-Term Assets	$6.951M	$7.440M	$6.833M
Total Assets	$11.79M	$14.37M	$13.53M
YoY Change	-0.43%	6.2%	265.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$794.1K	$900.0K	$712.3K
YoY Change	-7.09%	26.36%	121.21%
Accrued Expenses	$476.1K	$510.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.693M	$3.584M	$3.813M
YoY Change	84.05%	-6.01%	1084.31%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.693M	$3.584M	$3.813M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$3.855M	$3.776M	$3.813M
YoY Change	75.34%	-0.98%	1084.31%
SHAREHOLDERS EQUITY
Retained Earnings	-$25.15M	-$22.05M	-$14.46M
YoY Change	64.29%	52.49%
Common Stock	$1.528K	$1.528K	$922.00
YoY Change	62.38%	65.73%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$7.934M	$10.60M	$9.720M
YoY Change
Total Liabilities & Shareholders Equity	$11.79M	$14.37M	$13.53M
YoY Change	-0.43%	6.2%	265.1%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$3.102M	-$2.022M	-$2.398M
YoY Change	265.08%	-15.67%	78.8%
Depreciation, Depletion And Amortization	$222.2K	$210.0K	$127.1K
YoY Change	-40.17%	65.24%	4695.85%
Cash From Operating Activities	-$2.367M	-$2.010M	-$1.298M
YoY Change	15.92%	54.86%	139.19%
INVESTING ACTIVITIES
Capital Expenditures	$468.3K	-$110.0K	-$116.3K
YoY Change	-81.55%	-5.43%	-73.16%
Acquisitions
YoY Change
Other Investing Activities		-$200.0K	-$15.58K
YoY Change		1183.7%
Cash From Investing Activities	-$268.3K	-$90.00K	-$131.9K
YoY Change	55.38%	-31.77%	-69.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-370.0	4.790M	0.000
YoY Change			-100.0%
NET CHANGE
Cash From Operating Activities	-2.367M	-2.010M	-1.298M
Cash From Investing Activities	-268.3K	-90.00K	-131.9K
Cash From Financing Activities	-370.0	4.790M	0.000
Net Change In Cash	-2.636M	2.690M	-1.430M
YoY Change	19.02%	-288.14%	522.6%
FREE CASH FLOW
Cash From Operating Activities	-$2.367M	-$2.010M	-$1.298M
Capital Expenditures	$468.3K	-$110.0K	-$116.3K
Free Cash Flow	-$2.836M	-$1.900M	-$1.182M
YoY Change	-38.09%	60.8%	982.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001737995
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	STSS	Subsequent Events SubsequentEvents		usd
CY2022Q4	STSS	Subsequent Events SubsequentEvents		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	STSS	Fair Market Value Adjustment For Contingent Warrants FairMarketValueAdjustmentForContingentWarrants		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	STSS	Proceeds From Subscriptions Receivable ProceedsFromSubscriptionsReceivable		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	STSS	Common Stock Issued And Vested Stock Options For Fixed Assets Acquired CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired		usd
	STSS	Common Stock Issued And Vested Stock Options Issued As Consideration For Acquisition CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition		usd
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41355
	dei	Entity Registrant Name EntityRegistrantName	Sharps Technology, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-3751728
	dei	Entity Address Address Line1 EntityAddressAddressLine1	105 Maxess Road
	dei	Entity Address City Or Town EntityAddressCityOrTown	Melville
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11747
	dei	City Area Code CityAreaCode	(631)
	dei	Local Phone Number LocalPhoneNumber	574 -4436
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15274457	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5554417	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4170897	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	90397	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	66749	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	1287149	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	185804	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	6931963	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4423450	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6912891	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7004890	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	526766	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	411316	usd
CY2023Q3	us-gaap	Assets Assets	14371620	usd
CY2022Q4	us-gaap	Assets Assets	11839656	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	901802	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	543226	usd
CY2023Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	505839	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	311458	usd
CY2023Q3	STSS	Warrant Liability WarrantLiability	2176410	usd
CY2022Q4	STSS	Warrant Liability WarrantLiability	1151838	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3584051	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2006522	usd
CY2023Q3	STSS	Deferred Tax Liability DeferredTaxLiability	192000	usd
CY2022Q4	STSS	Deferred Tax Liability DeferredTaxLiability	192000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	3776051	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2198522	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15274457	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15274457	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9407415	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9407415	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	1528	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	941	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	32365838	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24733306	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	275568	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	214253	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22047365	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15307366	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	10595569	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9641134	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14371620	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11839656	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	225191	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	457627	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	783340	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1520870	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2133167	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1339448	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6425154	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4401158	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	2358358	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	1797075	usd
	us-gaap	Operating Expenses OperatingExpenses	7208494	usd
	us-gaap	Operating Expenses OperatingExpenses	5922028	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2358358	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1797075	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7208494	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5922028	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	17620	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	11332	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	94492	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1334612	usd
CY2023Q3	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	321981	usd
CY2022Q3	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-635283	usd
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	415958	usd
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	3443647	usd
CY2023Q3	STSS	Foreign Currency And Other Non Operating Income Expenses ForeignCurrencyAndOtherNonOperatingIncomeExpenses	-3587	usd
CY2022Q3	STSS	Foreign Currency And Other Non Operating Income Expenses ForeignCurrencyAndOtherNonOperatingIncomeExpenses	22903	usd
	STSS	Foreign Currency And Other Non Operating Income Expenses ForeignCurrencyAndOtherNonOperatingIncomeExpenses	-41955	usd
	STSS	Foreign Currency And Other Non Operating Income Expenses ForeignCurrencyAndOtherNonOperatingIncomeExpenses	22903	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	336014	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-601048	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	468495	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2131938	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2022344	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2398123	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6739999	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3790090	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.59
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.59
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.49
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.49
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11811492	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11811492	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9207386	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9207386	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11399657	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11399657	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7687940	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7687940	shares
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2022344	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2398123	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6739999	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3790090	usd
CY2023Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-283544	usd
CY2022Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-190863	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	61314	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-190863	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2305888	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2588986	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6678685	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3980953	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9641134	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2111830	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2783385	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	383100	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	270983	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	10966772	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2605825	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	254446	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	73876	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	8689269	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2022344	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	201365	usd
CY2023Q3	STSS	Stock Issued During Period Value Shelf Registration Offering StockIssuedDuringPeriodValueShelfRegistrationOffering	2458004	usd
CY2023Q3	STSS	Stock Issued During Period Value Private Placement StockIssuedDuringPeriodValuePrivatePlacement	1552819	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-283544	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	10595569	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3136197	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1869721	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	328460	usd
CY2022Q1	STSS	Stock Issued During Period Collections Of Common Stock Subscriptions Value StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue	32500	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1627436	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	477754	usd
CY2022Q2	STSS	Stock Issued During Period Value Initial Public Offering StockIssuedDuringPeriodValueInitialPublicOffering	8974657	usd
CY2022Q2	STSS	Stock Issued During Period Value Contingent Stock Liability StockIssuedDuringPeriodValueContingentStockLiability	496000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	365606	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	60551	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	12002004	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	12002004	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2398123	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2398123	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	306832	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	3470	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	9914182	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	9914182	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6739999	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3790090	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	656100	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	283189	usd
	STSS	Stockbased Compensation And Common Stock Issued For Services StockbasedCompensationAndCommonStockIssuedForServices	838911	usd
	STSS	Stockbased Compensation And Common Stock Issued For Services StockbasedCompensationAndCommonStockIssuedForServices	937402	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1299985	usd
	STSS	Fair Market Value Adjustment For Contingent Warrants FairMarketValueAdjustmentForContingentWarrants	-181000	usd
	STSS	Fair Market Value Adjustment For Contingent Warrants And Warrants FairMarketValueAdjustmentForContingentWarrantsAndWarrants	-415958	usd
	STSS	Fair Market Value Adjustment For Contingent Warrants And Warrants FairMarketValueAdjustmentForContingentWarrantsAndWarrants	-3262649	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	205112	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	550433	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-33729	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	8007	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	23032	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	68445	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1039152	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9961	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	12000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	339352	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-129877	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6144937	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4391020	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	232295	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	579683	usd
	STSS	Payments To Acquire Other Assets Escrow Deposit PaymentsToAcquireOtherAssetsEscrowDeposit	199084	usd
	STSS	Payments To Acquire Other Assets Escrow Deposit PaymentsToAcquireOtherAssetsEscrowDeposit	2365576	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-431379	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2945259	usd
	STSS	Net Proceeds From Initial Public Offering And Additional Offering NetProceedsFromInitialPublicOfferingAndAdditionalOffering	8029628	usd
	STSS	Net Proceeds From Initial Public Offering And Additional Offering NetProceedsFromInitialPublicOfferingAndAdditionalOffering	14202975	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2000000	usd
	STSS	Proceeds From Subscriptions Receivable ProceedsFromSubscriptionsReceivable	32500	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8029628	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12235475	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-69792	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11477	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1383520	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4910673	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4170897	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1479166	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5554417	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6389839	usd
	us-gaap	Interest Paid Net InterestPaidNet	47111	usd
	STSS	Fmv For Common Stock Issued For Contingent Shares FmvForCommonStockIssuedForContingentShares	496000	usd
	STSS	Common Stock Issued And Vested Stock Options For Fixed Assets Acquired CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired	63612	usd
	STSS	Common Stock Issued And Vested Stock Options Issued As Consideration For Acquisition CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition	60435	usd
CY2023Q3	STSS	Working Capital WorkingCapital	3347912	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_zMvw7q4U5RUl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zXWhG5jCF68c">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. As of September 30, 2023, the most significant estimates relate to derivative liabilities and stock-based compensation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	226124	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	106088	usd
CY2023Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	113467	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	49144	usd
CY2023Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	947558	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	30572	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	1287149	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	185804	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8239153	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7684614	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1326262	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	679724	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6912891	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7004890	usd
	us-gaap	Depreciation Depreciation	646538	usd
	us-gaap	Depreciation Depreciation	280053	usd
	STSS	Remaining Payments Due On Machinery RemainingPaymentsDueOnMachinery	100000	usd
CY2023Q3	us-gaap	Other Expenses OtherExpenses	716000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2800000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	455326	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	9000000.0	usd
CY2022Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	5200000	usd
	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	235000	shares
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	290551	usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	22470	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	42306	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	52818	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	62480	usd
CY2023Q3	us-gaap	Deposits Assets DepositsAssets	473578	usd
CY2022Q4	us-gaap	Deposits Assets DepositsAssets	336466	usd
CY2023Q3	STSS	Other Non Current OtherNonCurrent	370	usd
CY2022Q4	STSS	Other Non Current OtherNonCurrent	12370	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	526766	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	411316	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	10594	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	3136	usd
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000	shares
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2019Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000	shares
CY2019Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Conversion Of Stock Description ConversionOfStockDescription	Pursuant to the merger agreement, (i) the Company merged with and into Sharps Nevada, (ii) each 3.5 shares of common stock of the Company were converted into one share of common stock of Sharps Nevada and (iii) the articles of incorporation and bylaws of Sharps Nevada, became the articles of incorporation and bylaws of the surviving corporation.
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5600000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.3745	pure
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.4483	pure
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0358	pure
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0443	pure
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q3	STSS	Warrant Liability WarrantLiability	2176410	usd
CY2023Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	20406319	shares
CY2023Q3	STSS	Fair Market Value Of Note Warrants FairMarketValueOfNoteWarrants	30588	usd
CY2023Q3	STSS	Fair Market Value Of Trading And Overallotment Warrants FairMarketValueOfTradingAndOverallotmentWarrants	1121250	usd
CY2023Q3	STSS	Fair Market Value Of Trading And Overallotment Warrants Issuance FairMarketValueOfTradingAndOverallotmentWarrantsIssuance	455326	usd
CY2023Q3	STSS	Fair Market Value Of Trading And Overallotment Warrants Issuance One FairMarketValueOfTradingAndOverallotmentWarrantsIssuanceOne	985204	usd
CY2023Q3	STSS	Fair Market Value Of Change In Fair Value Of Warrant Liability FairMarketValueOfChangeInFairValueOfWarrantLiability	415958	usd
CY2023Q3	STSS	Warrant Liability WarrantLiability	2176410	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1358122	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.37
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1065000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.35
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	14286	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.75
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2408836	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.03
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1775243	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.57
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	576655	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	287298	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	876851	usd
CY2022Q3	STSS	Stock Based Charges Relating To Acquisition StockBasedChargesRelatingToAcquisition	19534	usd
	STSS	Stock Based Charges Relating To Acquisition StockBasedChargesRelatingToAcquisition	60435	usd
CY2022Q1	STSS	Stock Based Charges Relating To Purchase Of Machinery StockBasedChargesRelatingToPurchaseOfMachinery	63512	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Business EffectiveIncomeTaxRateReconciliationDispositionOfBusiness	0	pure
CY2023Q3	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Business EffectiveIncomeTaxRateReconciliationDispositionOfBusiness	0	pure
	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Business EffectiveIncomeTaxRateReconciliationDispositionOfBusiness	0	pure
CY2022Q3	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Business EffectiveIncomeTaxRateReconciliationDispositionOfBusiness	0	pure
CY2023Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	5554417	usd
CY2023Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	5554417	usd
CY2023Q3	STSS	Warrant Liability WarrantLiability	2176410	usd
CY2023Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	2176410	usd
	STSS	Order Costs To Purchase Equipment And Molds OrderCostsToPurchaseEquipmentAndMolds	459463	usd
	STSS	Progress Payments ProgressPayments	216714	usd
CY2023Q3	us-gaap	Severance Costs1 SeveranceCosts1	346000	usd
CY2023Q2	STSS	Medical Benefits Cost MedicalBenefitsCost	29000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	298000	usd
CY2023Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	235000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	50000	shares
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	1.30

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
stss-20230930_cal.xml	Edgar Link	unprocessable
0001493152-23-041085-index-headers.html	Edgar Link	pending
0001493152-23-041085-index.html	Edgar Link	pending
0001493152-23-041085.txt	Edgar Link	pending
0001493152-23-041085-xbrl.zip	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex10-1_001.jpg	Edgar Link	pending
ex10-1_002.jpg	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
stss-20230930.xsd	Edgar Link	pending
stss-20230930_def.xml	Edgar Link	unprocessable
stss-20230930_lab.xml	Edgar Link	unprocessable
stss-20230930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$STSS
Sharps Technology Inc. Stock $stss

2023 Q4 Form 10-Q Financial Statement

#000149315223041085 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STSS Sharps Technology Inc. Stock $stss

2023 Q4 Form 10-Q Financial Statement

#000149315223041085 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STSS
Sharps Technology Inc. Stock $stss